News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,930 Results
Type
Article (271)
Company Profile (2)
Press Release (12657)
Section
Business (7418)
Career Advice (7)
Deals (844)
Drug Development (940)
FDA (176)
Job Trends (257)
News (8725)
Policy (309)
Tag
Academia (23)
Allergies (4)
Alliances (297)
ALS (2)
Alzheimer's disease (21)
Antibody-drug conjugate (ADC) (2)
Approvals (188)
Artificial intelligence (5)
Autoimmune disease (4)
Automation (1)
Bankruptcy (5)
Best Places to Work (255)
Biosimilars (5)
Biotechnology (2)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (6)
Cancer (72)
Cardiovascular disease (4)
Career advice (7)
CAR-T (7)
Cell therapy (8)
Clinical research (872)
Collaboration (10)
Compensation (29)
Complete response letters (1)
COVID-19 (40)
C-suite (8)
Cystic fibrosis (1)
Data (140)
Depression (5)
Dermatology (2)
Diabetes (6)
Diagnostics (140)
Digital health (2)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (7736)
Events (1077)
Executive appointments (3)
FDA (287)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (11)
Generative AI (1)
Gene therapy (5)
GLP-1 (14)
Government (38)
Guidances (86)
Healthcare (538)
IgA nephropathy (2)
Immunology and inflammation (6)
Indications (3)
Infectious disease (41)
Inflammatory bowel disease (11)
Intellectual property (1)
Interviews (2)
IPO (722)
Job creations (17)
Job search strategy (6)
Layoffs (10)
Legal (48)
Liver cancer (2)
Lung cancer (6)
Lymphoma (14)
Machine learning (1)
Manufacturing (13)
MASH (8)
Medical device (405)
Medtech (409)
Mergers & acquisitions (133)
Metabolic disorders (26)
mRNA (3)
Multiple sclerosis (2)
Neurodegenerative disease (3)
Neuropsychiatric disorders (5)
Neuroscience (45)
NextGen: Class of 2026 (79)
Non-profit (27)
Obesity (9)
Pancreatic cancer (2)
Parkinson's disease (1)
Patents (2)
Patient recruitment (2)
Peanut (3)
People (365)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (225)
Phase 2 (351)
Phase 3 (365)
Pipeline (444)
Postmarket research (36)
Preclinical (52)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (15)
Real estate (21)
Regulatory (258)
Reports (1)
Research institute (32)
Rett syndrome (1)
Schizophrenia (4)
Series A (1)
Sickle cell disease (2)
Special edition (1)
Sponsored (1)
Startups (18)
Supply chain (2)
Tariffs (1)
Vaccines (18)
Venture capital (1)
Weight loss (7)
Women's health (3)
Date
Last 7 days (21)
Last 30 days (92)
Last 365 days (887)
2026 (235)
2025 (901)
2024 (1003)
2023 (1096)
2022 (2686)
2021 (1183)
2020 (1042)
2019 (702)
2018 (581)
2017 (392)
2016 (222)
2015 (395)
2014 (268)
2013 (140)
2012 (205)
2011 (224)
2010 (218)
Location
Africa (6)
Alabama (2)
Arizona (3)
Asia (614)
Australia (51)
California (370)
Canada (91)
China (11)
Colorado (16)
Connecticut (14)
Delaware (10)
Europe (1453)
Florida (87)
Georgia (18)
Idaho (1)
Illinois (26)
India (5)
Indiana (13)
Japan (7)
Kansas (2)
Kentucky (1)
Louisiana (3)
Maine (6)
Maryland (35)
Massachusetts (261)
Michigan (12)
Minnesota (17)
Missouri (1)
Nevada (7)
New Hampshire (4)
New Jersey (104)
New York (83)
North Carolina (75)
Northern California (171)
Ohio (13)
Pennsylvania (68)
South America (9)
Southern California (177)
Tennessee (6)
Texas (44)
United States (1316)
Utah (13)
Virginia (3)
Washington State (33)
Wisconsin (3)
12,930 Results for "246".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer’s Immunotherapy
October 2, 2025
·
3 min read
Press Releases
Immunology Market Poised for Growth, Expected to Hit USD 246.04 Billion by 2032 -Coherent Market Insights
July 10, 2025
·
1 min read
Press Releases
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
April 4, 2025
·
4 min read
Press Releases
ImmunityBio Reports 60% Increase in Revenue in Q2 2025, with Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code with Regulatory Updates
July 25, 2025
·
13 min read
Press Releases
Cholera Vaccines Market Size to Grow at 10.04% CAGR, Reaching $246 Mn by 2034
February 17, 2025
·
1 min read
Press Releases
ImmunityBio Reports Q2 Earnings Release Reflecting 60% Increase in Revenue in Q2 2025, With Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-code
August 6, 2025
·
19 min read
Press Releases
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
April 3, 2025
·
4 min read
Press Releases
Waldenstrom Macroglobulinemia Market Size to Reach USD 246.5 Million by 2035, Impelled by Advancements in Novel Therapies
February 13, 2025
·
11 min read
Press Releases
Cancer/Tumor Profiling Market Size to Reach USD 24.6 Billion by 2032, Impelled by Rapid Advancements in Genomic Technologies
August 7, 2024
·
11 min read
Asthma Spacers Market Size to Reach USD 2.46 Billion in 2028 Growing at a CAGR of 3.4%, According to Emergen Research
According to Emergen Research, the global asthma spacers market size was USD 1.91 billion in 2020 and is expected to reach USD 2.46 billion in 2028 and register a revenue CAGR of 3.4% during the forecast period, 2021-2028.
January 14, 2022
·
7 min read
1 of 1,293
Next
